World Advanced Therapies & Regenerative Medicine Congress

16–18 May 2018
Business Design Centre, London, UK

Research. Develop. Collaborate. Commercialise.

 

 

 

 
1000+
Attendees
300+
Speakers
60+
Exhibitors
6
Big Topics
3
Unmissable Days

Spotlight on speakers

 

Patrick Soon Shiong at World Advanced Therapies & Regenerative Medicine Congress
Patrick Soon Shiong
Chairman and Chief Executive Officer
NantKwest
Dr Margo R. Roberts at World Advanced Therapies & Regenerative Medicine Congress
Dr Margo R. Roberts
Chief Scientific Officer
Kite Pharma Inc
Susan L. Solomon at World Advanced Therapies & Regenerative Medicine Congress
Susan L. Solomon
Chief Executive Officer and Co-Founder
New York Stem Cell Foundation
Laszlo Radvanyi at World Advanced Therapies & Regenerative Medicine Congress
Laszlo Radvanyi
Senior Vice President, Senior Scientific Advisor
EMD Serono
Dr Jon Wigginton at World Advanced Therapies & Regenerative Medicine Congress
Dr Jon Wigginton
Chief Medical Officer
MacroGenics, Inc.
Dr Frédéric Triebel at World Advanced Therapies & Regenerative Medicine Congress
Dr Frédéric Triebel
Chief Scientific Officer and Medical Officer
Prima Biomed, Ltd
Stephen Badylak at World Advanced Therapies & Regenerative Medicine Congress
Stephen Badylak
Deputy Director, McGowan Institute for Regenerative Medicine
University of Pittsburgh
Keith Thompson at World Advanced Therapies & Regenerative Medicine Congress
Keith Thompson
Chief Executive Officer
Cell and Gene Therapy Catapult
Eric Soller at World Advanced Therapies & Regenerative Medicine Congress
Eric Soller
Vice President of Corporate Development & Strategy
BlueRock Therapeutics
Maya Furstenau Sharp at World Advanced Therapies & Regenerative Medicine Congress
Maya Furstenau Sharp
Marketing Manager for Regenerative Medicine
Sartorius

 

SEE MORE SPEAKERS

 

Save up to £600 - Early bird offer expires in

 

Days

Hours

Minutes

Seconds

 

REGISTER NOW

 

What is World Advanced Therapies & Regenerative Medicine Congress?

 

Conference

From clinical development to pricing, reimbursement and market access this congress will bring you the most exciting case studies and new data for immunotherapy, cell therapy, gene therapy, CARs and bioprocessing.

With so much content on offer you can choose the sessions most applicable to your business.

LEARN MORE

Exhibition

The exhibition features more than 60 exhibitors who will showcase the newest tech, software and developments the industry has to offer.

In 2018, we are again hosting the Innovation Zone with talks, panels and pitch and partners that could help you develop your business and take your work to the next level.
 

LEARN MORE

Networking

It’s not just about the conference sessions, our Congress recognises the importance of networking.

With roundtable discussions, themed networking receptions, networking lunches and our networking app we offer plenty of opportunities to network with your peers and continue conversations in good company.
 

LEARN MORE

Co-located with:

World Precision Medicine Congress



Focused on the precision medicine pipeline, from early discovery and development of drugs and diagnostics, through to implementation in clinics and hospitals.

Ethics, regulations and patient advocacy and involvement is also explored, with talks, roundtables and panels being run by top senior executives, clinicians, academics and thought leaders.

Attendees can move freely between events. 
 

LEARN MORE

Meet the expert speakers

 

  • Dr Bissan Al Lazikani at World Advanced Therapies & Regenerative Medicine Congress
    Dr Bissan Al Lazikani
    Head of Data Science
    Institute of Cancer Research
    Patrick Soon Shiong at World Advanced Therapies & Regenerative Medicine Congress
    Patrick Soon Shiong
    Chairman and Chief Executive Officer
    NantKwest
    Dr Margo R. Roberts at World Advanced Therapies & Regenerative Medicine Congress
    Dr Margo R. Roberts
    Chief Scientific Officer
    Kite Pharma Inc
  • Susan L. Solomon at World Advanced Therapies & Regenerative Medicine Congress
    Susan L. Solomon
    Chief Executive Officer and Co-Founder
    New York Stem Cell Foundation
    Abraham Heifets at World Advanced Therapies & Regenerative Medicine Congress
    Abraham Heifets
    Chief Executive Officer
    Atomwise Inc
    Laszlo Radvanyi at World Advanced Therapies & Regenerative Medicine Congress
    Laszlo Radvanyi
    Senior Vice President, Senior Scientific Advisor
    EMD Serono
  • Sue Hill at World Advanced Therapies & Regenerative Medicine Congress
    Sue Hill
    CSO
    NHS England
    Dr Jon Wigginton at World Advanced Therapies & Regenerative Medicine Congress
    Dr Jon Wigginton
    Chief Medical Officer
    MacroGenics, Inc.
    Nancy Krunic at World Advanced Therapies & Regenerative Medicine Congress
    Nancy Krunic
    VP, Global Head of Future Precision Medicine
    Novartis Oncology
  • Dr Frédéric Triebel at World Advanced Therapies & Regenerative Medicine Congress
    Dr Frédéric Triebel
    Chief Scientific Officer and Medical Officer
    Prima Biomed, Ltd
    Niven Narain at World Advanced Therapies & Regenerative Medicine Congress
    Niven Narain
    Co-Founder, President & CEO
    Berg Co Ltd
    Daniel Ray at World Advanced Therapies & Regenerative Medicine Congress
    Daniel Ray
    Director of Data
    NHS Digital
  • Stephen Badylak at World Advanced Therapies & Regenerative Medicine Congress
    Stephen Badylak
    Deputy Director, McGowan Institute for Regenerative Medicine
    University of Pittsburgh
    Keith Thompson at World Advanced Therapies & Regenerative Medicine Congress
    Keith Thompson
    Chief Executive Officer
    Cell and Gene Therapy Catapult
    Kari Stefansson at World Advanced Therapies & Regenerative Medicine Congress
    Kari Stefansson
    Chief Executive Officer
    Decode Genetics
  • Eric Soller at World Advanced Therapies & Regenerative Medicine Congress
    Eric Soller
    Vice President of Corporate Development & Strategy
    BlueRock Therapeutics
    Paul Peter Tak at World Advanced Therapies & Regenerative Medicine Congress
    Paul Peter Tak
    Senior Vice President of Research and Development Pipeline and Chief Immunology Officer
    GSK
    Thomas Hach at World Advanced Therapies & Regenerative Medicine Congress
    Thomas Hach
    Director HCS
    Novartis
  • Maya Furstenau Sharp at World Advanced Therapies & Regenerative Medicine Congress
    Maya Furstenau Sharp
    Marketing Manager for Regenerative Medicine
    Sartorius
    Zami Aberman at World Advanced Therapies & Regenerative Medicine Congress
    Zami Aberman
    Chairman and Chief Executive Officer
    Pluristem
    Dr Yen Choo at World Advanced Therapies & Regenerative Medicine Congress
    Dr Yen Choo
    Chief Executive Officer
    Progenitor Therapeutics
  • Francesco Dazzi at World Advanced Therapies & Regenerative Medicine Congress
    Francesco Dazzi
    Professor of Regenerative and Hematological Medicine
    King's College London
    Dr Ana Alfirevic at World Advanced Therapies & Regenerative Medicine Congress
    Dr Ana Alfirevic
    Senior Lecturer
    University of Liverpool
    Cédric Ghevaert at World Advanced Therapies & Regenerative Medicine Congress
    Cédric Ghevaert
    Senior Lecturer Transfusion Medicine
    University of Cambridge
  • Pedro Ballester at World Advanced Therapies & Regenerative Medicine Congress
    Pedro Ballester
    group leader
    INSERM
    Karina Bienfait at World Advanced Therapies & Regenerative Medicine Congress
    Karina Bienfait
    Principal Scientist and Head, Global Genomics Policy, Process and Compliance
    MSD
    Paul Peter Tak at World Advanced Therapies & Regenerative Medicine Congress
    Paul Peter Tak
    Senior Vice President of Research and Development Pipeline and Chief Immunology Officer
    GSK
  • Noel Burtt at World Advanced Therapies & Regenerative Medicine Congress
    Noel Burtt
    Associate Director of Operations, Diabetes Research
    Broad Institute of MIT & Harvard
    Damien Bates at World Advanced Therapies & Regenerative Medicine Congress
    Damien Bates
    Chief Medical Officer
    SanBio, Inc.
    Jane Dunnage at World Advanced Therapies & Regenerative Medicine Congress
    Jane Dunnage
    Patient and Public Involvement lead
    Lupus UK
  • Eduardo Bravo at World Advanced Therapies & Regenerative Medicine Congress
    Eduardo Bravo
    Chief Executive Officer
    TiGenix
    Wildon Farwell at World Advanced Therapies & Regenerative Medicine Congress
    Wildon Farwell
    Senior Director, Late Stage Clinical Development
    Biogen
    Benjamin Shepherd at World Advanced Therapies & Regenerative Medicine Congress
    Benjamin Shepherd
    Associate Director of R&D, Therapeutics
    Organovo
  • Dr Michael D West at World Advanced Therapies & Regenerative Medicine Congress
    Dr Michael D West
    CEO
    BioTime, Inc.
    Pantelis Georgiou at World Advanced Therapies & Regenerative Medicine Congress
    Pantelis Georgiou
    Reader in Biomedical Electronics, Department of Electrical and Electronic Engineering
    Imperial College London
    Jeffrey D Abbey at World Advanced Therapies & Regenerative Medicine Congress
    Jeffrey D Abbey
    President and Chief Executive Officer
    Argos Therapeutics
  • Joanne Hackett at World Advanced Therapies & Regenerative Medicine Congress
    Joanne Hackett
    Chief Commercial Officer
    Genomics England
    Diego Ardigo at World Advanced Therapies & Regenerative Medicine Congress
    Diego Ardigo
    Project Lead
    Chiesi Farmaceutici SpA
    Thomas Kaier at World Advanced Therapies & Regenerative Medicine Congress
    Thomas Kaier
    British Heart Foundation Research Fellow, Specialist Registrar in Cardiology
    King's College London
  • Domenick Bertelli at World Advanced Therapies & Regenerative Medicine Congress
    Domenick Bertelli
    Partner
    Putnam Associates
    Wen Bo Wang at World Advanced Therapies & Regenerative Medicine Congress
    Wen Bo Wang
    Senior Vice President Of Cell Therapy Research And Development
    Cellular Dynamics International Inc.
    Brian Bory at World Advanced Therapies & Regenerative Medicine Congress
    Brian Bory
    global poduct manager
    Sartorius Stedim North America
  • Dr Michael Kiebish at World Advanced Therapies & Regenerative Medicine Congress
    Dr Michael Kiebish
    Chief Precision Medicine Officer
    Berg Co Ltd
    Helena Kilpinen at World Advanced Therapies & Regenerative Medicine Congress
    Helena Kilpinen
    GOS Institute of Child Health
    UCL Great Ormond Street Institute of Child Health
    Evangelos Kiskinis at World Advanced Therapies & Regenerative Medicine Congress
    Evangelos Kiskinis
    Director Stem Cell Core Facility Co-Director, Stem Cell and Regenerative Biology
    Northwestern University
  • Didier Caizergues at World Advanced Therapies & Regenerative Medicine Congress
    Didier Caizergues
    Director of Regulatory Affairs
    Genethon
    Cecilia Lindskog at World Advanced Therapies & Regenerative Medicine Congress
    Cecilia Lindskog
    Director Tissue Atlas, Human Protein Atlas
    Uppsala University
    Kath Mackay at World Advanced Therapies & Regenerative Medicine Congress
    Kath Mackay
    Interim Deputy Director Health & Care
    Innovate UK
  • Jean Louis Mandel at World Advanced Therapies & Regenerative Medicine Congress
    Jean Louis Mandel
    Professor of Human Genetics
    Collège de France
    Pierre Meulien at World Advanced Therapies & Regenerative Medicine Congress
    Pierre Meulien
    Executive Director
    Innovative Medicines Initiative
    Nick Crabb at World Advanced Therapies & Regenerative Medicine Congress
    Nick Crabb
    Programme Director – Scientific Affairs
    NICE
  • Prof Sandosh Padmanabhan at World Advanced Therapies & Regenerative Medicine Congress
    Prof Sandosh Padmanabhan
    Professor of Cardiovascular Genomics and Therapeutics
    The University of Glasgow
    Eva Dahlen at World Advanced Therapies & Regenerative Medicine Congress
    Eva Dahlen
    Principal Scientist and Director Business Development
    Alligator Bioscience AB
    Vivienne Parry at World Advanced Therapies & Regenerative Medicine Congress
    Vivienne Parry
    Head of Engagement
    Genomics England
  • David Pearce at World Advanced Therapies & Regenerative Medicine Congress
    David Pearce
    Executive Vice President of Innovation and Research
    Sanford Research
    Dr Adam Platt at World Advanced Therapies & Regenerative Medicine Congress
    Dr Adam Platt
    Global Head of Genomics Portfolio, Head of the RIA Companion Diagnostic Unit (RIA CDU) in Personalised Healthcare and Biomarkers
    AstraZeneca
    Dr Suzanne Farid at World Advanced Therapies & Regenerative Medicine Congress
    Dr Suzanne Farid
    Biochemical Engineering Professor
    University College London
  • Paul Firuta at World Advanced Therapies & Regenerative Medicine Congress
    Paul Firuta
    Chief Commercial Officer
    uniQure
    Dr David Gilham at World Advanced Therapies & Regenerative Medicine Congress
    Dr David Gilham
    Vice President of Research and Development
    Celyad
    Riccardo Sabatini at World Advanced Therapies & Regenerative Medicine Congress
    Riccardo Sabatini
    Co-Founder, Chief Data Officer
    Orionis Biosciences
  • Andres A. Gutierrez at World Advanced Therapies & Regenerative Medicine Congress
    Andres A. Gutierrez
    Chief Medical Officer
    Oncolytics Biotech
    Lizzie Tuckey at World Advanced Therapies & Regenerative Medicine Congress
    Lizzie Tuckey
    Director of Clinical Strategy
    Bupa
    Frank Hecht at World Advanced Therapies & Regenerative Medicine Congress
    Frank Hecht
    Vice President Marketing and Sales
    CellGenix GmbH
  • Dr Mark Watson at World Advanced Therapies & Regenerative Medicine Congress
    Dr Mark Watson
    Head of Programmes
    Clinical Research Development Ireland
    Tony Whetton at World Advanced Therapies & Regenerative Medicine Congress
    Tony Whetton
    Director
    Stoller Biomarker Discovery Centre
    Mathew Woodwark at World Advanced Therapies & Regenerative Medicine Congress
    Mathew Woodwark
    Director of Research Bioinformatics
    Medimmune Ltd
  • Antoine HERON at World Advanced Therapies & Regenerative Medicine Congress
    Antoine HERON
    Cell Therapy Bioprocessing
    Merck-Millipore
    Hakim Yadi at World Advanced Therapies & Regenerative Medicine Congress
    Hakim Yadi
    CEO
    Northern Health Science Alliance
    Dr Ian Hudson at World Advanced Therapies & Regenerative Medicine Congress
    Dr Ian Hudson
    Chief Executive Officer
    Medicines and Healthcare Products Regulatory Agency
  • Silviu Itescu at World Advanced Therapies & Regenerative Medicine Congress
    Silviu Itescu
    CEO & Managing Director
    Mesoblast
    Alastair Kent OBE at World Advanced Therapies & Regenerative Medicine Congress
    Alastair Kent OBE
    Ambassador
    Genetic Alliance U.K.
    David Smith at World Advanced Therapies & Regenerative Medicine Congress
    David Smith
    Professor of Laboratory Medicine And Pathology
    Mayo Clinic
  • Michael Johnson at World Advanced Therapies & Regenerative Medicine Congress
    Michael Johnson
    Market Development Engineering Manager
    Entegris Inc
    Gil Alterovitz at World Advanced Therapies & Regenerative Medicine Congress
    Gil Alterovitz
    Director, Biomedical Cybernetics Laboratory Computational Health Informatics Program
    Harvard Medical School Department of Biomedical Informatics
    Dr Rosemary Barber at World Advanced Therapies & Regenerative Medicine Congress
    Dr Rosemary Barber
    Honorary Senior Research Fellow
    University of Sheffield
  • Jeffrey Barrett at World Advanced Therapies & Regenerative Medicine Congress
    Jeffrey Barrett
    Vice-President, Translational Informatics
    Sanofi Pharmaceuticals
    Ohad Karnieli at World Advanced Therapies & Regenerative Medicine Congress
    Ohad Karnieli
    Chief Executive Officer and Co Founder
    Atvio Biotechnology
    Maria Chatzou at World Advanced Therapies & Regenerative Medicine Congress
    Maria Chatzou
    Co-founder & Senior Advisor
    Innovation Forum
  • Charles Cox at World Advanced Therapies & Regenerative Medicine Congress
    Charles Cox
    Head of Pharmacogenetics, Genetics, Target Sciences
    GSK R&D
    Julien De Salaberry at World Advanced Therapies & Regenerative Medicine Congress
    Julien De Salaberry
    Managing Director
    Galen Growth Asia
    Steven Deitcher at World Advanced Therapies & Regenerative Medicine Congress
    Steven Deitcher
    CEO
    Medeor Therapeutics, Inc.
  • Juergen Eils at World Advanced Therapies & Regenerative Medicine Congress
    Juergen Eils
    Head of Data Management and Genomics IT
    German Cancer Research Center (DKFZ)
    David Fenstermacher at World Advanced Therapies & Regenerative Medicine Congress
    David Fenstermacher
    VP, R&D Bioinformatics
    MedImmune Inc
    Jane Lebkowski at World Advanced Therapies & Regenerative Medicine Congress
    Jane Lebkowski
    President of Research and Development
    Asterias Biotherapeutics Inc
  • Tony Freemont at World Advanced Therapies & Regenerative Medicine Congress
    Tony Freemont
    Director, MMPathIC
    The University of Manchester
    Jay Goth at World Advanced Therapies & Regenerative Medicine Congress
    Jay Goth
    Managing Partner
    Forentis Fund
    Karen Harrison at World Advanced Therapies & Regenerative Medicine Congress
    Karen Harrison
    Support Services Manager
    ALD Life
  • Michael Linden at World Advanced Therapies & Regenerative Medicine Congress
    Michael Linden
    VP Gene Therapy & Head, GMI
    Pfizer Ltd
    Enrico Heffler at World Advanced Therapies & Regenerative Medicine Congress
    Enrico Heffler
    Assistant Professor in Respiratory Medicine; Personalized Medicine, Asthma & Allergy Unit
    Humanitas University
    Giovanna Lombardi at World Advanced Therapies & Regenerative Medicine Congress
    Giovanna Lombardi
    Professor of Human Transplant Immunobiology
    King's College London
  • Ansar Jawaid at World Advanced Therapies & Regenerative Medicine Congress
    Ansar Jawaid
    Founder and Chief Executive Officer
    Precision Medicines
    Dr Danilo Maddalo at World Advanced Therapies & Regenerative Medicine Congress
    Dr Danilo Maddalo
    Laboratory Head
    Novartis Institutes for Biomedical Research
    John Maher at World Advanced Therapies & Regenerative Medicine Congress
    John Maher
    Chief Scientific Officer
    Leucid Bio
  • Melpomeni Kalofonou at World Advanced Therapies & Regenerative Medicine Congress
    Melpomeni Kalofonou
    Postdoctoral Researcher (Cancer Technology Lead)
    Imperial College London
    Dipak Kalra at World Advanced Therapies & Regenerative Medicine Congress
    Dipak Kalra
    President
    The European Institute for Innovation through Health Data
    Nikole Kimes at World Advanced Therapies & Regenerative Medicine Congress
    Nikole Kimes
    Co-Founder and Executive Vice President
    Siolta Therapeutics
  • Christophe Le Tourneau at World Advanced Therapies & Regenerative Medicine Congress
    Christophe Le Tourneau
    Head of Clinical Research, Department of Medical Oncology
    Curie Institute
    Shrikant Mane at World Advanced Therapies & Regenerative Medicine Congress
    Shrikant Mane
    Director
    Yale Center for Genome Analysis
    Giuseppe Mazza at World Advanced Therapies & Regenerative Medicine Congress
    Giuseppe Mazza
    Chief Executive & Scientific Officer
    Engitix
  • Joanne Mason at World Advanced Therapies & Regenerative Medicine Congress
    Joanne Mason
    Director of Sequencing and Sample Acquisition
    Genomics England
    Dr Todd McAllister at World Advanced Therapies & Regenerative Medicine Congress
    Dr Todd McAllister
    Executive Director
    Amnion Foundation
    Ian McKay at World Advanced Therapies & Regenerative Medicine Congress
    Ian McKay
    ‎Innovation Lead Advanced Therapies
    Innovate UK
  • Nick Medcalf at World Advanced Therapies & Regenerative Medicine Congress
    Nick Medcalf
    Innovation Lead - Advanced Therapies
    Innovate UK
    Marie Claire Parker at World Advanced Therapies & Regenerative Medicine Congress
    Marie Claire Parker
    Commercial Manager
    Stratified Medicine Scotland-Innovation Centre
    Sudhakaran Prabakaran at World Advanced Therapies & Regenerative Medicine Congress
    Sudhakaran Prabakaran
    Lecturer, Department of Genomics
    University of Cambridge
  • Janette Rawlinson at World Advanced Therapies & Regenerative Medicine Congress
    Janette Rawlinson
    Governance Board Member, Stratified Medicine Programme
    Cancer Research UK
    Joni Rutter at World Advanced Therapies & Regenerative Medicine Congress
    Joni Rutter
    Director of Scientific Programs, All of Us Research Proframme, Precision Medicine Initiative
    National Institutes of Health
    Matthieu-P. Schapranow at World Advanced Therapies & Regenerative Medicine Congress
    Matthieu-P. Schapranow
    Program Manager E-Health & Life Sciences
    Hasso Plattner Institute
  • Joanna Miller at World Advanced Therapies & Regenerative Medicine Congress
    Joanna Miller
    Chief Scientific Officer
    Cell Therapy Sciences
    Jacqui Shaw at World Advanced Therapies & Regenerative Medicine Congress
    Jacqui Shaw
    Professor of Translational Cancer Genetics
    University of Leicester
    Alain Thierry at World Advanced Therapies & Regenerative Medicine Congress
    Alain Thierry
    Director of Research
    INSERM
  • Clare Turnbull at World Advanced Therapies & Regenerative Medicine Congress
    Clare Turnbull
    Clinical Lead for 100,000 Genomes Project
    Genomics England
    Seshadri Vasan at World Advanced Therapies & Regenerative Medicine Congress
    Seshadri Vasan
    Senior Business Development Manager
    Public Health England
    Prof Norio Nakatsuji at World Advanced Therapies & Regenerative Medicine Congress
    Prof Norio Nakatsuji
    Chief Advisor
    Kyoto University
  • Julia Wilson at World Advanced Therapies & Regenerative Medicine Congress
    Julia Wilson
    Associate Director
    Wellcome Trust Sanger Institute
    James Noble at World Advanced Therapies & Regenerative Medicine Congress
    James Noble
    Chief Executive Officer
    Adaptimmune Ltd
    Prof Peder Olofsson at World Advanced Therapies & Regenerative Medicine Congress
    Prof Peder Olofsson
    Founding Director
    Karolinska University Hospital
  • Biju Parekkadan at World Advanced Therapies & Regenerative Medicine Congress
    Biju Parekkadan
    Co Founder
    Sentien Biotechnologies
    Detlev Parow at World Advanced Therapies & Regenerative Medicine Congress
    Detlev Parow
    Head of Department of Medicines, Therapeutic Appliances and Remedies
    D.A.K.
    Alex Pemberton at World Advanced Therapies & Regenerative Medicine Congress
    Alex Pemberton
    Lead Regenerative Medicine Programme Manager
    Medical Research Council
  • Sarah Pitluck at World Advanced Therapies & Regenerative Medicine Congress
    Sarah Pitluck
    Head, Global Pricing & Reimbursement
    Spark Therapeutics
    Dr Qasim Rafiq at World Advanced Therapies & Regenerative Medicine Congress
    Dr Qasim Rafiq
    Associate Professor, Bioprocessing of Cell and Gene Therapies
    University College London
    Ajan Reginald at World Advanced Therapies & Regenerative Medicine Congress
    Ajan Reginald
    CEO
    Celixir
  • Rodney Rietze at World Advanced Therapies & Regenerative Medicine Congress
    Rodney Rietze
    Lead CGMP Process Automation
    Novartis
    Paula Salmikangas at World Advanced Therapies & Regenerative Medicine Congress
    Paula Salmikangas
    Director for Biopharmaceuticals & ATMPs
    N.D.A. Regulatory Advisory Board
    Roger Smith at World Advanced Therapies & Regenerative Medicine Congress
    Roger Smith
    Professor of Equine Orthopaedics
    Royal Veterinary College
  • Christos Sotirelis at World Advanced Therapies & Regenerative Medicine Congress
    Christos Sotirelis
    Patient Representative
    UK Thalassaemia Society
    Katy Spink at World Advanced Therapies & Regenerative Medicine Congress
    Katy Spink
    Chief Operating Officer
    Asterias Biotherapeutics Inc
    Michael Stein at World Advanced Therapies & Regenerative Medicine Congress
    Michael Stein
    Chief Executive Officer
    Oxstem
  • Hardy Tadahisa S Kagimoto at World Advanced Therapies & Regenerative Medicine Congress
    Hardy Tadahisa S Kagimoto
    President and Chief Executive Officer
    Healios
    Marc Turner at World Advanced Therapies & Regenerative Medicine Congress
    Marc Turner
    Medical Director
    Scottish National Blood Transfusion Service
    Alain Vertes at World Advanced Therapies & Regenerative Medicine Congress
    Alain Vertes
    Managing Director
    NxR Biotechnologies
  • Dr Mark Zimmerman at World Advanced Therapies & Regenerative Medicine Congress
    Dr Mark Zimmerman
    Vice President, Business Development and Strategy
    ViaCyte

 

SEE MORE SPEAKERS

 

REGISTER NOW

Save up to £600 when you book by 23 February


Choose your package

Standard Package


Individual Pass

£1,995

Final Price £2,595

BOOK NOW

 

Group Booking of 3 or more

£1,495

Final Price £1,945

BOOK NOW

Academics


Individual Pass

£1,000

Final Price £1,300

BOOK NOW

 

Group Booking of 3 or more

£750

Final Price £975

BOOK NOW

Cord Blood Banks


Individual Pass

£495

Final Price £595

BOOK NOW

 

Group Booking of 3 or more

£370

Final Price £445

BOOK NOW

 

Companies that attend include

 

ABB    ABPI   Absorption    Adaptimmune   Advatis    Alliance for Regenerative Medicine   Amgen    Amnion Foundation   ANGLE Europe Ltd    Ancestry   Andalusian Initiative for Advanced Therapies    Anthony Nolan   Antleron    apceth   Argos Therapeutics    Argos Therapeutics   Arthritis Research UK    Association of the British Pharmaceutical Industry   Astellas    Astellas Pharma EMEA   Asterias Biotherapeutics Inc    AstraZeneca   Asymptote    Athersys   Autolus    Avectas   Bach Mai Hospital    BBC   BBI    Benevolent A.I.   Bio-cord    Bioheart, Inc.   Biomerieux    Bionix Ltd   BioProcess International    Biosafe SA   Biotechpharma    Biovault   Bluechiip    Blue Rock Therapeutics   Bone Therapeutics    Boston Scientific   Brigham and Women's Hospital    British Heart Foundation   Broad Center at University of Southern California    C.A.S.M.I. University of Oxford   Cambridge Enterprise    Cambridge Design Partnership   Caridianbct    Carolinas Cord Blood Bank At Duke   CCRM Centre for Commercialization of Regenerative    Celixir   Cell and Gene Therapy Catapult    Cell Therapies at Peter MacCallum   Cell Therapies Pte Ltd    Cell Therapy Manufacturing CRC   CellData Services    CellforCure   Cellular Biomedicine Group    Cellular Dynamics   CellProthera    Ceutiqus Pty Ltd   Chatham House    Chemelot Campus   Chemetec Allerod Denmark    Chemometec   Children's Hospital Los Angeles    CHUV Lausanne University Hospital   Cincinatti Children's Hospital Medical Center    Cira Kyoto University   CIRM    clean cells   Clinical Trials Unit, Skåne University    Clinigen Group Plc   Closter Pharma    Clyde Biosciences   Cognate BioServices    COMECER Group   Cook Regentec    Coulter Partners   Crisprtx    Cryo Save Labs Nv   Cryosite Ltd    CSEM SA   Cure Holdings    Cynata Therapeutics   Deva Medical Electronics Ltd    D.G. Health European Commission   Diamond Biopharm    Doc K medical   Edison Investment Research    EDQM   EGE University    Elanix Biotechnologies Ag   Endotronix Inc    Epidarex Capital   ERA Consulting (UK) Ltd    EuroClone   Excalibur Fund Managers Ltd    Ferrer International   Finnish Red Cross Blood Service    Fisher BioServices UK   Foundation for Biomedical Research and Innovation    Fraunhofer Institute for Cell Therapy and Immunology   Fresenius Kabi Deutschland GmbH    Frey Lifescience Consulting   Froceth    Future Medicine Ltd   Future Science Group    G.E. Healthcare UK   GE Healthcare Life Sciences    Genecode   GlexoSmithKline Ltd    GSRAC   Harvard Medical School    Healios   Hestia Investments    Histogenics Corporation   Holostem Terapie Avanzate    human med AG   Human Tissue Authority    Imperial College London   Imperial Innovations    InGeneron GmbH   Innovate UK    Institut fuer Bildgebende Diagnostik   Institute for Frontier Medical Scientes Kyoto University    Institute for Integrated Cell - Material Sciences Kyoto University   Institute for Medical Engineering and Science Harvard MIT Division of Health Sciences and Technology    Invetech   IRBA    Keren Mechkarim Tel-Hashomer (Sheba Medical Center)   Klinika Cellthera    Janssen Research & Development   Jellagen Pty Ltd    Juvenile Diabestes Research Foundation   Juventas Therapeutics    Kaiser Optical   Keele University    Kidney Research UK   LABS Inc.    Leucid Bio Ltd   Lifecell International Private Limited    Linkoping University   London Regenerative Medicine Network    Lonza   Loughbourough Univeristy    Marken   MaSTherCell    MaxCyte   MedCision    MedCity   Medical Products Agency Lakemedelsverket    Medical Research Council   Medicines and Healthcare Products Regulatory Agency    Medinet Co Ltd   Merck Millipore    Mesoblast   MHRA    Miltenyi Biotec   Moorfields Eye Hospital    Motor Neurone Disease Association   Multifacet Biosolutions Ltd    N.D.A. Regulatory Science Ltd   Nanogenics    National Institute for Health and Care Excellence   National Institute of Biomedical Innovation Health and Nutrition    NDA Group   NeoStem    New Scientist   Newcastle University Medical School    NHS Blood and Transplant   NHS Foundation Trust    Nicholls Spinal Injury Foundation   NICE    Nikon   Norgine Ltd    Novadip   Novartis Cell and Gene Therapy Unit    Novartis Institutes for Biomedical Research   NTU Singapore    NxR Biotechnologies   NY Stem Cell Foundation    Ocata Therapeutics   Octane Inc    Olympus   Orchard Therapeutics    ORIG3N   Organovo    Orgenesis Inc   Oxford BioMedica    Pall Bioforte   Pall Life Sciences    PBKM   PCT, a Caladrius company    PCT Cell Therapy Services   Peprotech    Pfizer   Pfizer Regenerative Medicine    Pharma Cell Bv   Pharma Lex GmbH    Plasticell   Pinnacle Pain Center    Pluristem Therapeutics   PM Group    Precious Cells International Ltd   Procaps Sa    Progenitor Therapeutics   Promethera Biosciences    Propagenix Inc.   Proteus Venture Partners    Quintiles IMS   Ravimiamet    Regenerative Medicine International   RegenMedTX    Regenrative Medical Solutions   Regiente/SBI Graduate School    ReNeuron Group Plc   Roboleo and Co    Rochester Institute of Technology   Roslin Cells Ltd    Royal Veterinary College   Ryboquin Company Ltd    Saint Gobain Life Sciences   Sanford Burnham Prebys Medical Discovery Institute    Sartorius Stedim Biotech GmbH   Save Your Skin    Scottish Development Inc.   Scottish National Blood Transfusion Service    Scinogy Pty Ltd   Semmelweis University of Medicine    SERVA Electrophoresis GmbH   SGS, Vitrology    SIMBEC-ORION Group Ltd   Sistemic Limited    SK Bioland   Smith and Newphew    Sony   Spiber Technologies Ab    St. Anne's University Hospital Brno, ICRC   St Lawrence College    St Vincent's Hospital   StemBioSys Inc    StemCell2Max   Stemedica    Stevenage Bioscience Catalyst   SynGen Inc.    Synpromics Ltd   Takara Bio Europe    Takara Clontech   Takeda Pharmaceutical Company    TC Biopharm   Tecomak Environmental Services Ltd    Terumo BCT   The ALS Association    The Electrospinning Company Ltd   The Wellcome Trust    Thermofisher   TiGenix    Tocris Bioscience   Touchstone Innovations    Trakcel Ltd   UK Stem Cell Foundation    UKSCF   UMCU    Universal Cells   University College London    University hospital Ostravs   University of Aberdeen    University of Birmingham   University of Ottawa    University of Oxford   University of Palermo - Dipartamento STEBICEF    University of Pittsburgh   UPM    USC Marshall School of Business   Valentech (Valentech Pharma Colombia SAS)    Vet Stem Inc   ViaCyte    Videregen   Vilnius University    Vinmec International Hospital   VivaBioCell Spa    VMD   Voisin Consulting Life Sciences    Vrije Universiteit Brussel   Wanbishi Archives co.    West Pharma   World Courier    Wuxi AppTec Inc   Xpand Biotechnology B.V.

 

FIND OUT MORE

 

Sign Up for Event Updates

Sponsors & Exhibitors

 

  • Silver Sponsor

    Miltenyi Biotec Ltd at World Advanced Therapies & Regenerative Medicine Congress

    Platinum Sponsor

    PCT at World Advanced Therapies & Regenerative Medicine Congress

    Platinum Sponsor

    Sartorius Stedim Biotech U.K. at World Advanced Therapies & Regenerative Medicine Congress
  • Platinum Sponsor

    Thermo Fisher Scientific Inc at World Advanced Therapies & Regenerative Medicine Congress

    Gold Sponsor

    Cell and Gene Therapy Catapult at World Advanced Therapies & Regenerative Medicine Congress

    Gold Sponsor

    Fujifilm Diosynth Biotechnologies U.S.A., Inc. at World Advanced Therapies & Regenerative Medicine Congress
  • Gold Sponsor

    Terumo BCT at World Advanced Therapies & Regenerative Medicine Congress

    Silver Sponsor

    Anemocyte at World Advanced Therapies & Regenerative Medicine Congress

    Silver Sponsor

    Cellular Dynamics International at World Advanced Therapies & Regenerative Medicine Congress
  • Silver Sponsor

    Cryoport Inc at World Advanced Therapies & Regenerative Medicine Congress

    Silver Sponsor

    ENTEGRIS at World Advanced Therapies & Regenerative Medicine Congress

    Silver Sponsor

    Irvine Scientific at World Advanced Therapies & Regenerative Medicine Congress
  • Silver Sponsor

    Maxcyte at World Advanced Therapies & Regenerative Medicine Congress

    Silver Sponsor

    Merck Millipore at World Advanced Therapies & Regenerative Medicine Congress

    Silver Sponsor

    Nono Nordisk Pharmatech A/S at World Advanced Therapies & Regenerative Medicine Congress
  • Silver Sponsor

    Viz.Ai at World Advanced Therapies & Regenerative Medicine Congress

    Associate Sponsor

    Alira Health at World Advanced Therapies & Regenerative Medicine Congress

    Associate Sponsor

    CellGenix GmbH at World Advanced Therapies & Regenerative Medicine Congress
  • Associate Sponsor

    Macopharma at World Advanced Therapies & Regenerative Medicine Congress

    Associate Sponsor

    N.D.A. Regulatory Science Ltd at World Advanced Therapies & Regenerative Medicine Congress

    Associate Sponsor

    Putnam Associates at World Advanced Therapies & Regenerative Medicine Congress
  • Exhibitor

    BioIVT at World Advanced Therapies & Regenerative Medicine Congress

    Exhibitor

    Metabolon Inc at World Advanced Therapies & Regenerative Medicine Congress

    Exhibitor

    Aber Instruments Ltd at World Advanced Therapies & Regenerative Medicine Congress
  • Exhibitor

    Advatis at World Advanced Therapies & Regenerative Medicine Congress

    Exhibitor

    Avm Biotechnology at World Advanced Therapies & Regenerative Medicine Congress

    Exhibitor

    Bio-Techne at World Advanced Therapies & Regenerative Medicine Congress
  • Exhibitor

    Biomerieux at World Advanced Therapies & Regenerative Medicine Congress

    Exhibitor

    E.T.H. Zurich at World Advanced Therapies & Regenerative Medicine Congress

    Exhibitor

    Euroclone Ltd. at World Advanced Therapies & Regenerative Medicine Congress
  • Exhibitor

    Labs, Inc at World Advanced Therapies & Regenerative Medicine Congress

    Exhibitor

    MaSTherCell at World Advanced Therapies & Regenerative Medicine Congress

    Exhibitor

    PeproTech at World Advanced Therapies & Regenerative Medicine Congress
  • Exhibitor

    PL BioScience GmbH at World Advanced Therapies & Regenerative Medicine Congress

    Exhibitor

    Roche Diagnostics at World Advanced Therapies & Regenerative Medicine Congress

    Exhibitor

    Skills Alliance at World Advanced Therapies & Regenerative Medicine Congress
  • Exhibitor

    VivaBioCell at World Advanced Therapies & Regenerative Medicine Congress

    Exhibitor

    World Courier at World Advanced Therapies & Regenerative Medicine Congress

 

SPONSORSHIP OPPORTUNITIES

 

Sponsorship packages are tailored to meet your specific business development goals
 

DOWNLOAD PROSPECTUS

See you in London  |  16th - 18th May

 

 

REGISTER NOW

World Advanced Therapies & Regenerative Medicine Congress

TO SPONSOR / EXHIBIT

Erica Baeta
+44 (0)207 092 1152
erica.baeta@terrapinn.com

TO SPEAK

Jessica Robinson
t/ +44 (0)207 092 1150
jessica.robinson@terrapinn.com

TO REGISTER

Issa Mauthoor
+44 (0)207 092 1257
issa.mauthoor@terrapinn.com